Literature DB >> 19942814

Proteomic analysis of focal cerebral ischemic injury in male rats.

Phil-Ok Koh1.   

Abstract

The present study identified the proteins that are differentially expressed during ischemic brain injury. Adult male rats were performed a middle cerebral artery occlusion (MCAO) to induce cerebral ischemia, and brains were collected at 24 hr after MCAO. Protein analysis was performed on the cerebral cortex using two-dimensional gel electrophoresis. Protein spots with a greater than 3 fold change in intensity between the sham and MCAO groups were identified by mass spectrometry. Among these proteins, 60 kDa heat shock protein, dehydropyrimidinase-related protein 2, t-complex protein 1, and Rho GDP dissociation inhibitor levels were significantly increased in MCAO group compared to those of the sham group. In contrast, thioredoxin, peroxiredoxin-2, stathmin, ubiquitin carboxy-terminal hydrolase L1, guanine nucleotide-binding protein alpha, pyridoxal-5'-phosphate phosphatase, and apoplipoprotein A-I levels were significantly decreased in MCAO group. These results suggest that cerebral ischemia induces neuronal cells death by changing expression levels of several proteins.

Entities:  

Mesh:

Year:  2009        PMID: 19942814     DOI: 10.1292/jvms.09-0364

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  11 in total

1.  Proteomic-Based Approaches for the Study of Ischemic Stroke.

Authors:  Haiying Li; Wanchun You; Xiang Li; Haitao Shen; Gang Chen
Journal:  Transl Stroke Res       Date:  2019-07-05       Impact factor: 6.829

Review 2.  Effects of Peroxiredoxin 2 in Neurological Disorders: A Review of its Molecular Mechanisms.

Authors:  Jifei Liu; Gang Su; Juan Gao; Ye Tian; Xiaoyan Liu; Zhenchang Zhang
Journal:  Neurochem Res       Date:  2020-01-30       Impact factor: 3.996

3.  Sex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusion.

Authors:  Fabio Di Domenico; Gabriella Casalena; Jia Jia; Rukhsana Sultana; Eugenio Barone; Jian Cai; William M Pierce; Chiara Cini; Cesare Mancuso; Marzia Perluigi; Catherine M Davis; Nabil J Alkayed; D Allan Butterfield; Allan D Butterfield
Journal:  J Neurochem       Date:  2012-03-28       Impact factor: 5.372

4.  Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury.

Authors:  Andrew K Ottens; Liliana Bustamante; Erin C Golden; Changping Yao; Ronald L Hayes; Kevin K W Wang; Frank C Tortella; Jitendra R Dave
Journal:  J Neurotrauma       Date:  2010-10-09       Impact factor: 5.269

Review 5.  Stroke Proteomics: From Discovery to Diagnostic and Therapeutic Applications.

Authors:  Karin Hochrainer; Wei Yang
Journal:  Circ Res       Date:  2022-04-14       Impact factor: 23.213

Review 6.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

7.  Focal Cerebral Ischemia Reduces Protein Phosphatase 2A Subunit B Expression in Brain Tissue and HT22 Cells.

Authors:  Phil-Ok Koh
Journal:  Lab Anim Res       Date:  2011-03-25

8.  Proteomic identification of proteins differentially expressed in response to resveratrol treatment in middle cerebral artery occlusion stroke model.

Authors:  Fawad-Ali Shah; Sang-Ah Gim; Myeong-Ok Kim; Phil-Ok Koh
Journal:  J Vet Med Sci       Date:  2014-07-07       Impact factor: 1.267

9.  Hyperglycemia decreases preoxiredoxin-2 expression in a middle cerebral artery occlusion model.

Authors:  Phil-Ok Koh
Journal:  Lab Anim Res       Date:  2017-06-30

10.  Epigallocatechin Gallate Alleviates Down-Regulation of Thioredoxin in Ischemic Brain Damage and Glutamate-Exposed Neuron.

Authors:  Dong-Ju Park; Ju-Bin Kang; Murad-Ali Shah; Phil-Ok Koh
Journal:  Neurochem Res       Date:  2021-07-29       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.